K. N. Gavrilov et al. / Tetrahedron: Asymmetry 23 (2012) 1052–1057
1055
purchased from Aldrich and Acros Organics and used without
further purification.
3. Conclusion
In conclusion, we have described the successful application of
novel C1-symmetric P,P-bidentate diastereomeric diphosphorami-
dites in Pd-catalyzed asymmetric allylations and in Rh-catalyzed
asymmetric hydrogenations. These ligands have the advantage of
being readily prepared in a few steps from commercial (S)-pyroglu-
tamic acid and (Sa)- or (Ra)-BINOL, low-cost chiral precursors. For
all of the investigated catalytic reactions we found that the abso-
lute configuration of the binaphthyl moieties unequivocally deter-
mines the absolute configuration of the products obtained. In some
cases, the asymmetric induction was very sensitive to the solvent
4.2. General procedure for the preparation of ligands 3a,b
A solution of diamine 1 (0.19 g, 1 mmol) in toluene (7 mL) was
added dropwise to a vigorously stirred solution of the appropriate
enantiomer 2a or 2b (0.7 g, 2 mmol), Et3N (0.7 mL, 5 mmol), and
DMAP (0.024 g, 0.2 mmol) in toluene (10 mL). The mixture was
then heated to boiling point, stirred for 30 min, and then cooled
to 20 °C. The resulting suspension was filtered through a short plug
of aluminum oxide, the column was washed twice with toluene
(8 mL) and the solvent evaporated under reduced pressure
(40 Torr). The product was dried in vacuo (1 Torr, 1 h).
nature. In particular, in the Rh-catalyzed hydrogenations of
a-
dehydrocarboxylic acid esters, the strongly polar CF3CH2OH was
the solvent of choice. A comparison of the results obtained with
the novel diphosphoramidites 3a,b and well-known L1a–d [up to
95% and 80% ee in Rh-catalyzed hydrogenation of (Z)-methyl 2-
acetamido-3-phenylacrylate, respectively]16 and L2a,b [up to 84%
and 75% ee in Pd-catalyzed alkylation of (E)-1,3-diphenylallyl ace-
tate with dimethyl malonate, respectively]20 showed that 3a,b are
comparable or even more efficient stereoselectors. As a result,
additional studies highlighting the potential of these new ligands
in other asymmetric reactions are currently in progress in our
laboratories.
4.2.1. (Sa,Sa)-N-Benzyl-N-(((2S)-1-(dinaphtho[2,1-d:10,20-f][1,3,
2]dioxaphosphepin-4-yl)pyrrolidin-2-yl)methyl)dinaphtho[2,1-
d:10,20-f][1,3,2]dioxaphosphepin-4-amine 3a
White powder (0.68 g, yield 83%). ½a D20
¼ þ168:7 (c 1.0, CHCl3).
ꢁ
1H NMR (CDCl3, 25 °C): d = 1.62–1.75 (m, 4H, CH2CH2), 2.60–2.68
(m, 1H, 2(CH2N)), 2.78–2.92 (m, 3H, 2(CH2N)), 3.86 (dd,
3
2JH,H = 14.7 Hz, JH,P = 8.3 Hz, 1H, CH2, Bn), 4.11–4.19 (m, 1H,
CHN), 4.26 (dd, JH,H = 14.7 Hz, JH,P = 5.4 Hz, 1H, CH2, Bn), 7.21–
7.28 (m, 3H, CH, aryl), 7.36–7.52 (m, 16H, CH, aryl), 7.69 (d,
3JH,H = 9.0 Hz, 1H, CH, aryl), 7.91–8.08 (m, 9H, CH, aryl). 13C{H}
NMR (CDCl3, 25 °C): dC = 24.0 (s, CH2); 29.6 (d, 3J = 3.9 Hz, CH2);
44.8 (d, 2J = 5.5 Hz, CH2N); 49.0 (d, 2J = 9.9 Hz, CH2N); 49.9 (dd,
2J = 27.6 Hz, 3J = 6.0 Hz, CH2N); 55.7 (d, 2J = 28.1 Hz, CHN); 121.8,
121.9 (s, CH, binaphthyl); 122.1 (d, 3J = 1.7 Hz, CH, binaphthyl);
122.3 (s, CH, binaphthyl); 122.5 (d, 3J = 2.2 Hz, C, binaphthyl);
122.6 (d, 3J = 2.2 Hz, C, binaphthyl); 124.1, 124.2 (s, C, binaphthyl);
124.6, 124.7, 124.8, 124.9, 125.4, 126.1 (s, CH, binaphthyl); 126.2
(br s, 2 ꢀ CH, binaphthyl); 126.9 (s, CH, phenyl); 127.1 (br s,
2 ꢀ CH, phenyl); 127.4 (s, CH, binaphthyl); 128.2 (br s, 2 ꢀ CH, phe-
nyl); 128.3 (s, CH, binaphthyl); 128.4 (br s, 3 ꢀ CH, binaphthyl);
129.0 (br s, 2 ꢀ CH, binaphthyl); 129.1, 129.8, 130.2, 130.3, 130.4
(s, CH, binaphthyl); 130.7, 130.8, 131.4, 131.5, 132.6, 132.8,
132.9, 133.0 (s, C, binaphthyl); 137.7 (s, C, phenyl); 149.4 (s, CO,
binaphthyl); 149.8 (d, 2J = 3.3 Hz, CO, binaphthyl); 149.9 (d,
2J = 2.2 Hz, CO, binaphthyl); 150.6 (d, 2J = 4.4 Hz, CO, binaphthyl).
MS (MALDI TOF/TOF), m/z (I, %): = 819 (18) [M+H]+, 505 (100)
[MꢂC20H12O2P+2H]+, 316 (47) [C20H12O2PH]+. Anal. Calcd for
C52H40N2O4P2: C, 76.27; H, 4.92; N, 3.42. Found: C, 76.51; H,
4.87; N, 3.61.
4. Experimental
4.1. General
31P, 13C and 1H NMR spectra were recorded with a Bruker AMX
400 instrument (162.0 MHz for 31P, 100.6 MHz for 13C and
400.13 MHz for 1H). The complete assignment of all of the reso-
nances in the 13C NMR spectra was achieved by the use of DEPT
techniques and published data.35 Chemical shifts (ppm) were given
relative to Me4Si (1H and 13C) and 85% H3PO4 31P NMR). Mass
(
spectra are recorded with a Bruker Daltonics Ultraflex spectrome-
ter (MALDI TOF/TOF). HPLC analyses were performed on an Agilent
1100 and Stayer instruments using ChiralcelÒ columns. GC was
performed on an Agilent 6890 chromatograph with a Lipodex E
column. Optical rotations were measured on a Perkin–Elmer 341
polarimeter. Elemental analyses were performed at the Laboratory
of Microanalysis (Institute of Organoelement Compounds,
Moscow).
All manipulations were carried out under a dry argon atmo-
sphere in flame-dried glassware and in freshly dried and distilled
solvents. For example, toluene and tetrahydrofuran were freshly
distilled from sodium benzophenone ketyl before use; dichloro-
methane was distilled from NaH. Triethylamine was distilled
over KOH and then over a small amount of LiAlH4 before use.
Column chromatography was performed using silica gel MN Kie-
selgel 60 (230–400 mesh) and MN-Aluminum oxide, basic,
Brockmann Activity 1. Enantiomeric phosphorylating reagents—
(Sa)-2-chlorodinaphtho[2,1-d:10,20-f][1,3,2] dioxaphosphepine 2a
and (Ra)-2-chlorodinaphtho[2,1-d:10,20-f][1,3,2] dioxaphosphepine
2b were prepared according to the literature.39 Pd(allyl)Cl]2 and
starting substrate 5 were prepared analogously to the known
procedures.40 Pd-catalyzed allylic substitution: sulfonylation of
substrate 5 with sodium p-toluenesulfinate and alkylation with
dimethyl malonate were performed according to the appropriate
procedures.36 [Rh(cod)2]BF4 and starting substrate 7b were pre-
4.2.2. (Ra,Ra)-N-Benzyl-N-(((2S)-1-(dinaphtho[2,1-d:10,20-f][1,3,
2]dioxaphosphepin-4-yl)pyrrolidin-2-yl)methyl)dinaphtho[2,1-
d:10,20-f][1,3,2]dioxaphosphepin-4-amine 3b
White powder (0.71 g, yield 87%). ½a D20
¼ þ122:3 (c 1.0, CHCl3).
ꢁ
1H NMR (CDCl3, 25 °C): d = 1.36–1.44 (m, 1H, CH2CH2), 1.46–1.56
(m, 2H, CH2CH2), 1.69–1.77 (m, 1H, CH2CH2), 2.63–2.72 (m, 1H,
2
2(CH2N)), 3.03–3.15 (m, 3H, 2(CH2N)), 3.78 (br d, JH,H = 15.0 Hz,
2
1H, CH2, Bn), 3.86–3.94 (m, 1H, CHN), 4.20 (br d, JH,H = 15.0 Hz,
1H, CH2, Bn), 7.14–7.25 (m, 6H, CH, aryl), 7.32–7.45 (m, 10 H, CH,
3
aryl), 7.49 (d, JH,H = 8.9 Hz, 1H, CH, aryl), 7.55–7.66 (m, 3H, CH,
aryl), 7.78–8.03 (m, 9H, CH, aryl). 13C{H} NMR (CDCl3, 25 °C):
dC = 24.7 (s, CH2); 28.8 (d, 3J = 4.0 Hz, CH2); 43.2 (s, CH2N); 48.8
(br s, CH2N); 50.4 (dd, 2J = 32.7 Hz, 3J = 4.1 Hz, CH2N); 56.6 (dd,
2J = 31.4 Hz, 3J = 3.4 Hz, CHN); 121.9, 122.1 (s, CH, binaphthyl);
122.2 (d, 3J = 3.4 Hz, CH, binaphthyl); 122.3 (s, CH, binaphthyl);
122.9, 123.0 (s, C, binaphthyl); 123.8 (d, 3J = 4.7 Hz, C, binaphthyl);
124.1 (d, 3J = 5.4 Hz, C, binaphthyl); 124.4 (br s, 2 ꢀ CH, binaph-
thyl); 124.5, 124.7, 125.7, 125.8, 125.9, 126.0, 126.7, 126.8, 126.9,
127.0, 127.1 (s, CH, binaphthyl); 128.1 (s, CH, phenyl); 128.2 (br
s, 2 ꢀ CH, phenyl); 128.3 (br s, 3 ꢀ CH, binaphthyl); 128.7 (br s,
2 ꢀ CH, phenyl); 129.7, 129.9, 130.0, 130.1, (s, CH, binaphthyl);
pared as published.41,42 Rh-catalyzed hydrogenation of
a-dehy-
drocarboxylic acid esters 7a,b was performed as published.43
(Sa)- and (Ra)-BINOL, DMAP (4-dimethylamino-pyridine), di-
methyl malonate, BSA (N,O-bis(trimethylsilyl) acetamide), so-
dium p-toluenesulfinate and dimethyl itaconate 7a were